Inhibition of eEF2 phosphorylation through genetic or pharmacological approaches improved multiple aspects of DS‐associated pathophysiology including protein synthesis deficiency, synaptic failure, and cognitive impairments. This evidence concerns the gene EEF2 and Cognitive impairment.